| Screening and treatment program to eliminate hepatitis C in Egypt I Waked, G Esmat, A Elsharkawy, M El-Serafy, W Abdel-Razek, R Ghalab, ... New England Journal of Medicine 382 (12), 1166-1174, 2020 | 229 | 2020 |
| A multinational Delphi consensus to end the COVID-19 public health threat JV Lazarus, D Romero, CJ Kopka, SA Karim, LJ Abu-Raddad, G Almeida, ... Nature 611 (7935), 332-345, 2022 | 177 | 2022 |
| Patient care and clinical outcomes for patients with COVID-19 infection admitted to African high-care or intensive care units (ACCCOS): a multicentre, prospective … BM Biccard, PD Gopalan, M Miller, WL Michell, D Thomson, A Ademuyiwa, ... The Lancet 397 (10288), 1885-1894, 2021 | 153 | 2021 |
| Age and frailty are independently associated with increased COVID-19 mortality and increased care needs in survivors: results of an international multi-centre study C Welch Age and ageing 50 (3), 617-630, 2021 | 117 | 2021 |
| Clinical study evaluating the efficacy of ivermectin in COVID‐19 treatment: A randomized controlled study S Abd‐Elsalam, RA Noor, R Badawi, M Khalaf, ES Esmail, S Soliman, ... Journal of medical virology 93 (10), 5833-5838, 2021 | 115 | 2021 |
| Transarterial chemoembolization combined with either radiofrequency or microwave ablation in management of hepatocellular carcinoma AO Abdelaziz, AH Abdelmaksoud, MM Nabeel, HI Shousha, AA Cordie, ... Asian Pacific Journal of Cancer Prevention: APJCP 18 (1), 189, 2017 | 42 | 2017 |
| RETRACTED ARTICLE: Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: A multicenter Egyptian study M El-Bendary, S Abd-Elsalam, T Elbaz, W El-Akel, A Cordie, T Elhadidy, ... Expert Review of Anti-infective Therapy 20 (2), 291-295, 2022 | 37 | 2022 |
| De-novo versus recurrent hepatocellular carcinoma following direct-acting antiviral therapy for hepatitis C virus AO Abdelaziz, MM Nabil, AH Abdelmaksoud, HI Shousha, AA Cordie, ... European Journal of Gastroenterology & Hepatology 30 (1), 39-43, 2018 | 29 | 2018 |
| Comparing the efficiency of Fib‐4, Egy‐score, APRI, and GUCI in liver fibrosis staging in Egyptians with chronic hepatitis C A Cordie, A Salama, M El‐Sharkawy, SM El‐Nahaas, M Khairy, ... Journal of medical virology 90 (6), 1106-1111, 2018 | 25 | 2018 |
| COVID-19 vaccine acceptance and associated factors among people living with HIV in the Middle East and North Africa region R Mohamed, TM White, JV Lazarus, A Salem, R Kaki, W Marrakchi, ... Southern African journal of HIV medicine 23 (1), 2022 | 12 | 2022 |
| Sustained virologic response and changes in liver fibrosis parameters following 12-wk administration of generic sofosbuvir and daclatasvir in HIV/HCV-coinfected patients with … A Cordie, A Elsharkawy, S Abdel Alem, S Meshaal, W El Akel, Z Abdellatif, ... Transactions of The Royal Society of Tropical Medicine and Hygiene 114 (4 …, 2020 | 10 | 2020 |
| Evaluation of accuracy of elastography point quantification versus other noninvasive modalities in staging of fibrosis in chronic hepatitis C virus patients R Fouad, T Elbaz, SA Alem, A Elsharkawy, M Negm, M Khairy, M Hassany, ... European Journal of Gastroenterology & Hepatology 30 (8), 882-887, 2018 | 10 | 2018 |
| DAAs therapy associated with improved hepatic fibrosis in HCV-GT4 patients co-infected with HIV H El-Garem, M AbdAllah, H Omar, A Cordie, S Abdel Alem, ... Expert Review of Gastroenterology & Hepatology 13 (7), 693-698, 2019 | 9 | 2019 |
| Forecasted impacts of a sofosbuvir-based national hepatitis C treatment programme on Egypt’s hepatocellular cancer epidemic: simulation of alternatives W Ma, AS Soliman, WA Anwar, A Hablas, TB El Din, M Ramadan, ... BMJ Global Health 3 (2), e000572, 2018 | 9 | 2018 |
| Antiretroviral therapy optimisation in the time of COVID-19: Is it really different in North and South Africa? A Cordie, G Esmat Southern African Journal of HIV Medicine 21 (1), 2020 | 6 | 2020 |
| Human immunodeficiency virus (HIV) and coronavirus disease 2019; impact on vulnerable populations and harnessing lessons learnt from HIV programmes A Cordie, M AbdAllah, A Vergori, B Kharono, M Karkouri, G Esmat New Microbes and New Infections 41, 100857, 2021 | 5 | 2021 |
| COVID-19: a strong call for remote medicine in inflammatory bowel disease. M Khorshid, N Bakheet, S Abdallah, M Essam, A Cordie | 5 | 2020 |
| Safety and efficacy of the generic products of sofosbuvir and daclatasvir in treatment of HCV genotype 4 Egyptian patients A Elsharkawy, M Hashem, R Fouad, M Negm, A Cordie, MI Mehrez Merit Res J Medicine Med Sci 5, 209-213, 2017 | 5 | 2017 |
| HIV-related stigma and discrimination by healthcare workers in Egypt YS Galal, WA Khairy, R Mohamed, G Esmat, M Negm, WHA Alaty, ... Transactions of The Royal Society of Tropical Medicine and Hygiene 116 (7 …, 2022 | 4 | 2022 |
| HCV/HIV coinfected Egyptian patients: a cross-sectional study of their main characteristics and barriers to HCV treatment initiation R Eletreby, G Esmat, A Elsharkawy, L Alsehemy, R Mohamed, SA Alem, ... Transactions of The Royal Society of Tropical Medicine and Hygiene 116 (3 …, 2022 | 4 | 2022 |
